EMEA-002311-PIP01-17-M02

Table of contents

Key facts

Invented name
Trogarzo
Active substance
Ibalizumab
Therapeutic area
Infectious diseases
Decision number
P/0248/2021
PIP number
EMEA-002311-PIP01-17-M02
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Intravenous use
Contact for public enquiries
Theratechnologies International Limited

Tel. +1 5143367800
E-mail: regulatoryaffairs@theratech.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
1 rating